Hematologic malignancies, or blood cancers, affect the production and function of your blood cells. Most of these cancers start in the bone marrow where blood is produced. Stem cells in the bone marrow mature and develop into three types of blood cells: red blood cells, white blood cells or platelets. In most blood cancers, the normal blood cell development process is interrupted by uncontrolled growth of an abnormal type of blood cell. These abnormal blood cells, or cancerous cells, prevent the blood from performing many of its functions, like fighting off infections or preventing serious bleeding.
There are three main types of blood cancers: leukemia, a type of cancer found in your blood and bone marrow, caused by the rapid production of abnormal white blood cells; lymphoma, a type of blood cancer that affects the lymphatic system, which removes excess fluids from your body and produces immune cells; and myeloma, a cancer of the plasma cells.
The Hematologic Malignancies Center and George L. Strike Bone Marrow Transplant Program at the University of Cincinnati Cancer Center has physicians that specialize in the treatment of these blood diseases. Treating these diseases often involves using stem cells to help build or rebuild the immune system.
Researchers within the center are also working to discover the underlying reasons these cancers develop while improving standardized treatments for better patient outcomes.
Teams of scientists within the center are conducting novel clinical trials and research studies that could lead to new therapies for patients with hematologic malignancies. Experts within the center offer knowledge backed by the latest discovery-driven medical concepts, research studies and clinical trials only available at major academic health centers.
Contact UsUniversity of Cincinnati
231 Albert Sabin Way, Suite 2005
Cincinnati, OH 45267